OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
10
Results
Show all
Save search
Copy query
Show results for
Unknown
(10)
Publication Date
Release Date
2025
(2)
2016
(2)
2012
(2)
2023
(1)
2022
(1)
2018
(1)
2017
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
A second update on mapping the human genetic architecture of COVID-19.
Not available
S-EPMC10482689
|
biostudies-literature
Cite
Metformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocol.
Not available
S-EPMC12303861
|
biostudies-literature
Cite
Novel genetic loci underlying human intracranial volume identified through genome-wide association.
Not available
S-EPMC5227112
|
biostudies-literature
Cite
Common variants at 12q14 and 12q24 are associated with hippocampal volume.
Not available
S-EPMC3427729
|
biostudies-literature
Cite
GWAS and colocalization analyses implicate carotid intima-media thickness and carotid plaque loci in cardiovascular outcomes.
Not available
S-EPMC6277418
|
biostudies-literature
Cite
Identification of common variants associated with human hippocampal and intracranial volumes.
Not available
S-EPMC3635491
|
biostudies-literature
Cite
Novel genetic loci associated with hippocampal volume.
Not available
S-EPMC5253632
|
biostudies-literature
Cite
Genetic influences on schizophrenia and subcortical brain volumes: large-scale proof of concept.
Not available
S-EPMC4852730
|
biostudies-literature
Cite
Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico.
Not available
S-EPMC8693692
|
biostudies-literature
Cite
Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer: the STAMPEDE Phase 3 Randomized Clinical Trial.
Not available
S-EPMC11869088
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets